PL330797A1 - Derivatives of piperidinacetic acid and their application in treating thrombotic disorders - Google Patents

Derivatives of piperidinacetic acid and their application in treating thrombotic disorders

Info

Publication number
PL330797A1
PL330797A1 PL97330797A PL33079797A PL330797A1 PL 330797 A1 PL330797 A1 PL 330797A1 PL 97330797 A PL97330797 A PL 97330797A PL 33079797 A PL33079797 A PL 33079797A PL 330797 A1 PL330797 A1 PL 330797A1
Authority
PL
Poland
Prior art keywords
derivatives
application
thrombotic disorders
treating thrombotic
piperidinacetic
Prior art date
Application number
PL97330797A
Other languages
English (en)
Inventor
David George Allen
Colin David Eldred
Brian David Judkins
William Leonard Mitchell
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9613017.4A external-priority patent/GB9613017D0/en
Priority claimed from GBGB9613095.0A external-priority patent/GB9613095D0/en
Priority claimed from GBGB9613018.2A external-priority patent/GB9613018D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PL330797A1 publication Critical patent/PL330797A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL97330797A 1996-06-21 1997-06-19 Derivatives of piperidinacetic acid and their application in treating thrombotic disorders PL330797A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9613017.4A GB9613017D0 (en) 1996-06-21 1996-06-21 Therapeutic compounds
GBGB9613095.0A GB9613095D0 (en) 1996-06-21 1996-06-21 Therapeutic piperidines
GBGB9613018.2A GB9613018D0 (en) 1996-06-21 1996-06-21 Therapeutic indazoles
PCT/EP1997/003196 WO1997049699A1 (fr) 1996-06-21 1997-06-19 Derives piperidine de l'acide acetique et leur utilisation dans le traitement des troubles thrombotiques

Publications (1)

Publication Number Publication Date
PL330797A1 true PL330797A1 (en) 1999-06-07

Family

ID=27268341

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97330797A PL330797A1 (en) 1996-06-21 1997-06-19 Derivatives of piperidinacetic acid and their application in treating thrombotic disorders

Country Status (17)

Country Link
EP (1) EP0912555A1 (fr)
JP (1) JP2000512648A (fr)
KR (1) KR20000022041A (fr)
AP (1) AP9801417A0 (fr)
AR (1) AR008245A1 (fr)
AU (1) AU3261197A (fr)
BR (1) BR9709930A (fr)
CA (1) CA2258753A1 (fr)
CZ (1) CZ424698A3 (fr)
EA (1) EA199801015A1 (fr)
ID (1) ID17052A (fr)
IL (1) IL127464A0 (fr)
IS (1) IS4924A (fr)
NO (1) NO985974L (fr)
PL (1) PL330797A1 (fr)
TR (1) TR199802665T2 (fr)
WO (1) WO1997049699A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1401831A1 (fr) 2001-07-03 2004-03-31 Chiron Corporation Composes d'indazole benzimidazole utilises comme inhibiteurs de tyrosine et de serine/threonine kinase
US7642278B2 (en) 2001-07-03 2010-01-05 Novartis Vaccines And Diagnostics, Inc. Indazole benzimidazole compounds
TW200401641A (en) 2002-07-18 2004-02-01 Wyeth Corp 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands
RU2347780C2 (ru) * 2003-02-14 2009-02-27 Уайт Гетероциклил-3-сульфонилиндазолы в качестве лигандов 5-гидрокситриптамина-6
AU2007235499A1 (en) 2006-04-05 2007-10-18 Wyeth Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands
BRPI0806542A2 (pt) 2007-01-10 2014-04-22 Hoffmann La Roche Derivados de sulfonamida como inibidores de quimase
CN113655155A (zh) * 2021-07-28 2021-11-16 任贤金 一种测定sph3127有关物质的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4124942A1 (de) * 1991-07-27 1993-01-28 Thomae Gmbh Dr K 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
AU2915892A (en) * 1991-11-14 1993-06-15 Glaxo Group Limited Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
GB9208740D0 (en) * 1992-04-23 1992-06-10 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
ID17052A (id) 1997-12-04
KR20000022041A (ko) 2000-04-25
NO985974D0 (no) 1998-12-18
EP0912555A1 (fr) 1999-05-06
NO985974L (no) 1999-02-17
AP9801417A0 (en) 1998-12-31
BR9709930A (pt) 1999-08-10
IL127464A0 (en) 1999-10-28
IS4924A (is) 1998-12-15
WO1997049699A1 (fr) 1997-12-31
CA2258753A1 (fr) 1997-12-31
TR199802665T2 (xx) 1999-03-22
JP2000512648A (ja) 2000-09-26
AU3261197A (en) 1998-01-14
EA199801015A1 (ru) 1999-08-26
CZ424698A3 (cs) 1999-05-12
AR008245A1 (es) 1999-12-29

Similar Documents

Publication Publication Date Title
HUP9800033A3 (en) Compositions for the treatment of dermatological disorders and methods for their use
PL331861A1 (en) Derivatives of propionic acid and their application
AU3339897A (en) Sulphonamide derivatives and their use in the treatment of cns disorders
GB9422571D0 (en) Haemorrihoidal compositions and method of use
EP0782399A4 (fr) Concentre d'acide hydroxycitrique et son procede de fabrication
IL127594A0 (en) Device for topical treatment of acne and its method of manufacture
AU2462697A (en) Skin tightening formulation and method of treating skin
EP0758196A4 (fr) Compositions et procedes de traitement de tumeurs
US5656608B1 (en) Amino acid compositions and methods of treatment using same
IL136110A0 (en) Methods and compositions for the treatment of psoriasis
NO970582D0 (no) Fremgangsmåte og blandinger nyttige i protylakse og behandling av endotoksin-relaterte tilstander
GB9507415D0 (en) Production and uses of caffeic acid and derivatives thereof
IL116142A0 (en) Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis
PL332579A1 (en) Application of 1-hydroxy-2-pyridinones in treating dermatological infections
EP1030663A4 (fr) Traitement de fibromyalgie et de troubles qui y sont lies
PL330797A1 (en) Derivatives of piperidinacetic acid and their application in treating thrombotic disorders
HUP0201299A2 (en) Device for topical treatment of acne and its method of manufacture
PL335688A1 (en) Novel derivatives of carboxylic acid, method of obtaining them and their application in treating carcinoma
AU3261097A (en) Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders
PL324929A1 (en) Cosmetic method of treating and preventing the symptoms of skin ageing
EP0835092A4 (fr) Composition et traitement pour la lutte contre la calvitie
AU2705495A (en) Use of rooperol and hypoxoside and their derivatives in the treatment of inflammatory
GB2310318B (en) Ferroelectric component and method of manufacture
GB9609927D0 (en) Composition and method of treating skin disorders
GB9709769D0 (en) Composition and method of treating skin disorders